Citigroup’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-79,324
| Closed | -$301K | – | 5272 |
|
|
2020
Q1 | $301K | Buy |
79,324
+15,605
| +24% | +$59.2K | ﹤0.01% | 2609 |
|
|
2019
Q4 | $325K | Sell |
63,719
-188,504
| -75% | -$961K | ﹤0.01% | 2886 |
|
|
2019
Q3 | $1.28M | Buy |
252,223
+114,929
| +84% | +$581K | ﹤0.01% | 1939 |
|
|
2019
Q2 | $847K | Buy |
137,294
+70,412
| +105% | +$434K | ﹤0.01% | 2274 |
|
|
2019
Q1 | $311K | Sell |
66,882
-497,201
| -88% | -$2.31M | ﹤0.01% | 2829 |
|
|
2018
Q4 | $2.37M | Buy |
564,083
+466,669
| +479% | +$1.96M | ﹤0.01% | 1429 |
|
|
2018
Q3 | $611K | Sell |
97,414
-5,168
| -5% | -$32.4K | ﹤0.01% | 2371 |
|
|
2018
Q2 | $825K | Sell |
102,582
-8,215
| -7% | -$66.1K | ﹤0.01% | 2021 |
|
|
2018
Q1 | $827K | Sell |
110,797
-49,272
| -31% | -$368K | ﹤0.01% | 1950 |
|
|
2017
Q4 | $953K | Buy |
160,069
+4,866
| +3% | +$29K | ﹤0.01% | 1915 |
|
|
2017
Q3 | $1.14M | Sell |
155,203
-38,483
| -20% | -$283K | ﹤0.01% | 1847 |
|
|
2017
Q2 | $1.32M | Buy |
193,686
+101,518
| +110% | +$689K | ﹤0.01% | 1769 |
|
|
2017
Q1 | $870K | Sell |
92,168
-74,188
| -45% | -$700K | ﹤0.01% | 2046 |
|
|
2016
Q4 | $1.44M | Buy |
166,356
+151,321
| +1,006% | +$1.31M | ﹤0.01% | 2108 |
|
|
2016
Q3 | $95K | Buy |
15,035
+7,377
| +96% | +$46.6K | ﹤0.01% | 3429 |
|
|
2016
Q2 | $32K | Sell |
7,658
-51,230
| -87% | -$214K | ﹤0.01% | 3936 |
|
|
2016
Q1 | $257K | Buy |
58,888
+52,792
| +866% | +$230K | ﹤0.01% | 3273 |
|
|
2015
Q4 | $37K | Sell |
6,096
-76,070
| -93% | -$462K | ﹤0.01% | 4252 |
|
|
2015
Q3 | $470K | Buy |
82,166
+61,442
| +296% | +$351K | ﹤0.01% | 2247 |
|
|
2015
Q2 | $155K | Buy |
20,724
+4,908
| +31% | +$36.7K | ﹤0.01% | 2940 |
|
|
2015
Q1 | $95K | Sell |
15,816
-11,762
| -43% | -$70.6K | ﹤0.01% | 3438 |
|
|
2014
Q4 | $209K | Buy |
27,578
+25,016
| +976% | +$190K | ﹤0.01% | 3128 |
|
|
2014
Q3 | $14K | Buy |
2,562
+1,187
| +86% | +$6.49K | ﹤0.01% | 4469 |
|
|
2014
Q2 | $6K | Sell |
1,375
-14,372
| -91% | -$62.7K | ﹤0.01% | 4772 |
|
|
2014
Q1 | $64K | Sell |
15,747
-8,098
| -34% | -$32.9K | ﹤0.01% | 3824 |
|
|
2013
Q4 | $127K | Buy |
23,845
+9,992
| +72% | +$53.2K | ﹤0.01% | 3517 |
|
|
2013
Q3 | $70K | Buy |
13,853
+9,423
| +213% | +$47.6K | ﹤0.01% | 3411 |
|
|
2013
Q2 | $20K | Buy |
+4,430
| New | +$20K | ﹤0.01% | 4201 |
|